Peter Landstrom is the new permanent chief executive of Royal Free London NHS Foundation Trust
The NHS trust running Chase Farm Hospital has appointed a new permanent chief executive.
Royal Free London NHS Foundation Trust (RFL) announced today (Wednesday 11th) that Peter Landstrom had been given the role permanently, following a spell since May as acting chief executive.
Peter originally joined Royal Free in 2022 as group chief delivery officer and deputy group chief executive. He has held a number of senior leadership roles and has a strong NHS operational background, having first joined the service in 2003. He said taking on his new role was “an enormous privilege”.
Mark Lam, Royal Free chair, said: “On behalf of the board, I’m delighted to welcome Peter as the new group chief executive. During his time at the trust, Peter has been instrumental in setting a clear vision and direction for our organisation with a focus on ensuring our patients get the very best of the NHS when they walk through our doors.
“This includes a relentless focus on our performance amid the ongoing pressures faced by our trust and the entire NHS.
“I look forward to continuing to work closely with Peter as he leads the Royal Free London into the next chapter of its history. Along with the board of directors, I wish him every success.”
As well as running Chase Farm, Royal Free runs Barnet Hospital, Edgware Community Hospital and its largest site, Royal Free Hospital in Camden.
Peter has set the NHS trust’s clinical strategy for the future, with an emphasis on cardiovascular care, cancer, organ failure and transplantation, as well as developing local priorities for each of the hospital sites.
“It is an enormous privilege and honour to take on this role,” said Peter. “Since I started at the Royal Free London, I have been struck by just how much pride every single member of staff has in their services and by their absolute dedication to patients, our organisation and to each other.
“The challenges faced by the NHS are very real, but our commitment to providing clinical excellence with research at the heart of everything we do, alongside best in class education and training for our staff, means we have cause for optimism for the future. I look forward to working with colleagues and our partners to deliver world class care for our patients.”